Yes lets please mark that post. We will get more info on foreign distribution signed contracts or updates on clinical trials, either way a win win with price in .30's and possible low .40's as we have done before a couple of times or fda news with 1.00 to 3.00 price range with EUA but for sure in .30's in next couple of weeks, that's been the pattern lately with Decn. I actually believe in Pr's lately, why would Berman put out false updates after being under close scrutiny and slap on hand back in April by Sec.You may not like him but he's not stupid or incompetent. Why throw away a 18 year old business and possible delisting just to pump a couple million and risk jail time and lawsuits? Come on think about it, he has to have some validation to back up claims, Decn has been pretty transparent and upfront with Pr's since May. And whats going on behind the scenes with data from testing and SPECIFIC details about overseas contracts is really none of our business for now.